Form 4: Genting Berhad and Lim Kok Thay Report Acquisition of Celularity Inc. Warrants

Genting Berhad and Lim Kok Thay report the acquisition of 1,350,000 warrants in Celularity Inc., exercisable at $2.988 per share, along with a correction of previous filings regarding direct share ownership.

Summary

• Lim Kok Thay, a director and 10% owner of Celularity Inc., along with Genting Berhad, have reported the acquisition of 1,350,000 warrants to purchase Class A Common Stock.
• These warrants, exercisable at $2.988 per share, became reportable on July 15, 2024, when the exercise price was set.
• The warrants are held indirectly through Resorts World Inc Pte. Ltd. (RWI), with Genting Berhad and Mr. Lim each indirectly holding 50% of RWI.
• The report also corrects a previous filing error regarding Mr. Lim's direct ownership of Class A Common Stock, adjusting for a reverse stock split and a prior disposal of shares.
• The corrected direct ownership of Class A Common Stock for Mr. Lim is 2,531 shares.

Sentiment

Score: 6

Explanation: The document primarily reports a routine transaction and a correction of a previous error. While the warrant acquisition could be seen as a positive sign, it's not a major event that would significantly alter the company's outlook. The sentiment is neutral to slightly positive.

Positives

• The acquisition of warrants by a major shareholder and related entity could be seen as a positive sign of confidence in the company's future prospects.
• The correction of previous filing errors ensures transparency and accuracy in reporting.

Risks

• The exercise of the warrants could potentially dilute existing shareholders' equity if exercised.
• The indirect ownership structure through RWI adds complexity to the ownership structure.

Management Comments

• Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein.

Industry Context

This filing is a routine disclosure of changes in beneficial ownership by insiders, which is common in the biotechnology industry where Celularity operates. Such filings are closely monitored by investors for insights into management's confidence and potential future actions.

Comparison to Industry Standards

• The acquisition of warrants by insiders is a common practice in the biotech industry, often used as a form of incentive or investment.
• The reporting of these transactions is standard practice and is required by the SEC to ensure transparency.
• The correction of previous filing errors is also a standard practice to maintain accurate records.

Related Party Transactions

• The warrants are held by RWI, which is indirectly owned by Genting Berhad and Lim Kok Thay, indicating a related party transaction.

Stakeholder Impact

• The acquisition of warrants could be viewed positively by shareholders as it indicates confidence from insiders.
• The potential exercise of warrants could lead to dilution of existing shares.

Key Dates

Keywords

warrants, Celularity Inc, Lim Kok Thay, Genting Berhad, Class A Common Stock, derivative securities, beneficial ownership, reverse stock split, SEC Form 4